Legal News

The impact of coronavirus (COVID-19) on OTC derivatives

Published on: 30 March 2020
Published by: LexisPSL
  • The impact of coronavirus (COVID-19) on OTC derivatives
  • Which OTC derivatives are particularly affected by the pandemic?
  • Could some market disruption or other circumstances become Force Majeure events under the 2002 ISDA Master? What if a counterparty has a 1992 ISDA?
  • What adverse effects can market volatility caused by the pandemic have on OTC derivatives?
  • What prudent defensive measures should market participants be taking?
  • How are derivatives regulators responding to the pandemic?

Article summary

Banking & Finance analysis: Guy Dempsey, Of Counsel at Katten Muchin Rosenman LLP, and Carolyn Jackson, partner at Katten Muchin Rosenman UK LLP, and both P.R.I.M.E. Finance experts, discuss the impact of the coronavirus (COVID-19) on OTC derivatives, including which OTC derivatives are most affected by the pandemic, whether market disruption or other circumstances could become Force Majeure events, defensive measures market participants should be taking and how derivatives regulators are responding. or take a trial to read the full analysis.

Popular documents